ENCERT: A Multisite Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide, and Etoposide in Relapsed T‐Cell Lymphoblastic Leukemia/Lymphoma
Relapsed and refractory (R/R) T‐cell acute lymphoblastic leukemia/lymphoma (T‐ALL/T‐LL) remains a therapeutic challenge. Allogeneic hematopoietic stem cell transplantation (HSCT) after achieving complete remission (CR) offers the only chance of cure, but effective modalities to achieve CR are limited. Activation of mTO...